Vertex Pharmaceuticals Incorporated (VRTX) Income Annual - Discounting Cash Flows
VRTX
Vertex Pharmaceuticals Incorporated
VRTX (NASDAQ)
Period Ending: LTM
(Last Twelve Months)
2024
12-31
2023
12-31
2022
12-31
2021
12-31
2020
12-31
2019
12-31
2018
12-31
2017
12-31
2016
12-31
2015
12-31
2014
12-31
2013
12-31
2012
12-31
2011
12-31
2010
12-31
2009
12-31
2008
12-31
2007
12-31
2006
12-31
2005
12-31
2004
12-31
2003
12-31
2002
12-31
2001
12-31
2000
12-31
1999
12-31
1998
12-31
1997
12-31
1996
12-31
1995
12-31
1994
12-31
1993
12-31
1992
12-31
1991
12-31
1990
12-31
Report Filing 2025-11-04 2025-02-13 2024-02-15 2023-02-10 2022-02-09 2021-02-11 2020-02-13 2019-02-13 2018-02-15 2017-02-23 2016-02-16 2015-02-13 2014-02-11 2013-03-01 2012-02-22 2011-02-17 2010-02-19 2009-02-17 2008-02-11 2007-03-01 2006-03-16 2005-03-16 2004-03-15 2003-03-31 2002-04-01 2001-03-26 2000-03-03 1999-03-30 1998-03-26 1997-03-28 1995-12-31 1994-12-31 1993-12-31 1992-12-31 1991-12-31 1990-12-31
Revenue 11,723 11,020 9,869 8,931 7,574 6,206 4,163 3,048 2,489 1,702 1,032 580.4 1,212 1,527 1,411 143.4 102 175.5 199 216.4 160.9 102.7 69.14 161.1 167.5 78.13 61.6 44.4 43.8 13.3 22.1 19.6 27.9 3.8 3.2 2.3
Cost of Revenue 1,609 1,530 1,262 1,080 904.2 736.3 547.8 409.5 275.1 210.5 125.5 60.99 130.3 279.9 80.5 12.73 14.2 15.69 13.9 12.17 10.1 5.65 3.13 28.28 39.63 4.08 -3.4 -4.5 -3.6 -3.2 -3.7 -3.5 -3.9 -2.8 -1.8 0
Gross Profit 10,115 9,490 8,607 7,850 6,670 5,469 3,615 2,638 2,214 1,492 906.8 519.4 1,082 1,247 1,330 130.6 87.85 159.8 185.1 204.2 150.8 97.07 66.02 132.8 127.9 74.05 65 48.9 47.4 16.5 25.8 23.1 31.8 6.6 5 2.3
Operating Expenses 6,121 9,722 4,775 3,543 3,888 2,613 2,417 2,003 2,090 1,482 1,375 1,212 1,985 1,245 1,216 826.7 701.3 622.5 604.9 433.2 300.7 251.9 330.5 252.4 219.7 112.7 104.6 81.3 66.6 46.3 52.3 43.8 30.6 16.6 10.6 6.4
Research & Development 3,989 3,630 3,163 2,656 3,051 1,830 1,755 1,416 1,325 1,048 996.2 855.5 918.8 806.2 707.7 637.4 550.7 516.3 513.1 371.7 248.5 192.2 199.6 203 148.7 84.92 72.2 58.7 51.6 35.2 41.5 0 0 0 0 0
Selling, General and Administrative 1,644 1,464 1,137 944.7 840.1 770.5 658.5 557.6 496.1 432.8 377.1 305.4 362.3 436.8 400.7 187.8 129.3 101.9 84.73 57.86 43.99 42.14 39.08 49.39 47.34 27.81 26.1 18.1 11.4 7.9 7.1 40.3 26.7 13.8 8.8 6.4
Other Operating Expenses 488.5 4,628 475.5 -57.5 -3.1 13.05 4.46 28.82 269.6 1.26 2.21 50.92 704 1.84 107.9 1.5 21.28 4.32 7.12 3.65 8.13 17.57 91.82 0 23.65 0 6.3 4.5 3.6 3.2 3.7 3.5 3.9 2.8 1.8 0
Operating Income 3,993 -232.9 3,832 4,307 2,782 2,856 1,198 635.1 123.2 9.94 -468.7 -692.4 -903.4 2.33 113.8 -696.1 -613.4 -462.7 -419.8 -229 -149.9 -154.8 -264.5 -119.6 -91.8 -38.68 -39.6 -32.4 -19.2 -29.8 -26.5 -20.7 1.2 -10 -5.6 -4.1
Net Non-Operating Interest 484.4 567.5 570.6 89.8 -56.6 -35.95 5.18 -34.12 -57.55 -81.43 -84.21 -72.86 -22.73 -14.71 -34.7 -17.32 -8.18 2.86 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Interest Income 497.2 598.1 614.7 144.6 4.9 22.2 63.68 0 11.75 0 0 0 0 1.94 1.88 1.96 5.01 16.33 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Interest Expense 12.8 30.6 44.1 54.8 61.5 58.15 58.5 34.12 69.3 81.43 84.21 72.86 22.73 16.65 36.57 19.27 13.19 13.47 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Equity & Other Income/(Expense) -29.1 -86.1 -22.8 -164.8 4.9 296.6 192.2 -0.79 -81.38 4.13 -6.71 30.4 -49.94 -0 -18.68 -41.23 -20.58 -4.32 -7.12 22.15 -23.52 -3.7 -82.82 -0.055 -26.09 -14.93 -0.7 32.4 19.2 -9.7 5.5 3.6 0.9 2 0.8 4.1
Income Before Tax 4,449 248.5 4,380 4,232 2,730 3,117 1,395 600.2 -15.69 -67.37 -559.6 -734.9 -976.1 -12.38 60.45 -754.6 -642.2 -464.2 -426.9 -206.9 -173.4 -158.5 -347.3 -119.7 -117.9 -53.61 -40.3 0 0 -39.5 -21 -17.1 2.1 -8 -4.8 0
Income Tax Expense 773.6 784.1 760.2 910.4 388.3 405.2 218.1 -1,487 -107.3 16.66 30.38 6.96 -288.6 38.75 19.27 0 0 -30.73 -21.39 -18.5 61.68 29.01 24.06 -10.98 -1.92 0.976 1.4 0.7 0.6 10.2 -5 -3.1 0.1 -1.5 -0.5 4.3
Income Attributable to Non-Controlling Interest 0 0 0 0 0 0.049 0 -9.79 -171.8 28.02 -31.85 -3.28 -242.5 55.9 11.61 0 -0.6 26.41 -14.24 18.5 -31.65 -21.27 -174.6 -0.055 -49.74 -14.93 -0.7 32.4 19.2 -9.7 5.5 3.6 0 2 0.8 0
Net Income 3,675 -535.6 3,620 3,322 2,342 2,712 1,177 2,097 263.5 -112.1 -558.1 -738.6 -445 -107 29.57 -754.6 -641.6 -459.9 -391.3 -206.9 -203.4 -166.2 -196.8 -108.6 -66.23 -39.66 -41 -33.1 -19.8 -40 -21.5 -17.6 2 -8.5 -5.1 -4.3
Depreciation and Amortization 200.6 205.8 181.3 148.3 125.6 109.5 106.9 72.42 61.4 61.4 62.34 63.26 48.37 38.19 35.04 30.46 30.11 32.2 27.46 25.87 27.29 29.64 23.44 25.43 17.96 9.1 6.3 4.5 3.6 3.2 3.7 3.5 3.9 2.8 1.8 0
EBITDA 4,194 -27.1 4,013 4,456 2,908 2,966 1,305 707.6 184.6 71.33 -406.3 -629.2 -855.1 40.52 148.9 -665.6 -583.3 -430.5 -392.3 -203.2 -122.6 -125.2 -241.1 -94.17 -73.84 -29.59 -33.3 -27.9 -15.6 -26.6 -22.8 -17.2 5.1 -7.2 -3.8 -4.1
Earnings Per Share (EPS) 14.33 -2.08 14.05 12.97 9.09 10.44 4.58 8.25 1.06 -0.46 -2.32 -3.14 -1.98 -0.5 0.14 -3.77 -3.7 -3.27 -3.03 -1.83 -2.28 -2.12 -2.56 -1.43 -0.89 -0.59 -0.8 -0.65 -0.41 -1.07 -0.63 -0.56 0.08 -0.35 -0.35 -0.22
Diluted Earnings Per Share 14.18 -2.08 13.89 12.82 9.01 10.29 4.51 8.09 1.04 -0.46 -2.31 -3.14 -1.98 -0.5 0.14 -3.77 -3.7 -3.27 -3.03 -1.83 -2.28 -2.12 -2.56 -1.43 -0.89 -0.59 -0.8 -0.65 -0.41 -1.07 -0.63 -0.56 0.08 -0.35 -0.35 -0.22
Weighted Average Shares Outstanding 255.6 257.5 257.7 256.1 257.7 259.8 256.7 254.3 248.9 243.6 240.8 234.9 224.8 211.9 204.9 200.4 173.3 140.6 129 113.2 89.24 78.57 77 75.75 74.46 67.68 51.04 50.6 48.53 37.38 34.13 31.43 25 24.29 14.62 19.68
Diluted Weighted Average Shares Outstanding 257.6 257.9 260.5 259.1 259.9 263.4 260.7 259.2 253.2 244.7 241.3 235.3 224.9 211.9 208.8 200.4 173.3 140.6 129 113.2 89.24 78.57 77 75.75 74.46 67.68 51.04 50.6 48.53 37.38 34.13 31.43 25 24.29 14.62 19.68
discounting cash flows home logo

Discounting Cash Flows

Are you finding our services helpful? Review us on trustpilot logo Trustpilot
Have a question? Contact us
Want to become our sponsor?
Check out our Affiliate Program